Home nebulizers: can optimal therapy be predicted by laboratory studies?

Respiratory Medicine

Volumn 84, Issue 6, 1990, Pages 471-477

  O'Driscoll, B R ^a   Kay, E A ^a   Taylor, R J ^a   Bernstein, A ^a  

^a HOPE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IPRATROPIUM BROMIDE; SALBUTAMOL;

ADULT; AGED; ARTICLE; ASTHMA; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; NEBULIZATION; PRIORITY JOURNAL;

EID: 0025185450     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(08)80111-4     Document Type: Article

References (12)

1. Home Nebulisers for airflow limitation
2. Assessment of the clinical usefulness of nebulised ipratropium bromide in patients with chronic airflow limitation
3. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma
4. Domiciliary nebuliser therapy: a double blind dose response assessment
5. Comparison of domiciliary nebulised salbutamol and salbutamol from a metered dose inhaler in stable chronic airflow limitation
6. A comparison of metered dose inhalers with nebulisers for the delivery of ipratropium bromide in domiciliary practice
7. Domiciliary nebulised salbutamol solution in severe chronic airway obstruction
8. Home nebulisers in severe chronic asthma
9. Bronchoconstrictor properties of preservatives in ipratropium bromide (Atrovent) nebuliser solution
10. Role of the parasympathetic system in airway obstruction due to emphysema
11. Use of nebulised saline and nebulised terbutaline as an adjunct to chest physiotherapy
12. Dose response relation to oral theophylline in severe chronic obstructive airways disease